Ophthalmologic Drug Guide-..
até
4x
de
R$ 91,28
sem juros
ou R$ 346,88
via Pix
Adicionar ao carrinho
Disponibilidade: 45 dias úteis
Estoque: 180 unidades
-
- 1x de R$ 365,14 sem juros
- 2x de R$ 182,57 sem juros
- 3x de R$ 121,71 sem juros
- 4x de R$ 91,28 sem juros
-
R$ 346,88
-
R$ 365,14
Drug therapy as an alternative to surgical intervention is becoming increasingly common. In the past five years, new anti-glaucoma agents have becoming increasingly effective. This edition will include new information on off-label prescribing and cap colors where they are mandated by the FDA (pink/white for steroid drops, grey for topical NSAIDS, etc.);There are now several new pharmaceutical agents being used to treat retinal diseases such as age-related macular degeneration (Macugen, Lucentis, Visudyne), while other drugs formerly prescribed have now been shown to be less effective. Intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry eye markets continue to grow, with a new formulation of Allergan's Acular 0.5% (ketorolac tromethamine) and Elestat ophthalmic solution, its new antihistamine-mast cell stabilizer.
| ISBN | 9781441976208 |
| Autor(a) | Rhee, Douglas J. |
| Editora | Springer Publishing |
| Ano de edição | 2010 |
| Páginas | 138 |
| Acabamento | Brochura |
| Dimensões | 20,30 X 12,70 |
Produtos relacionados
-
Drug Resistance-..R$ 2.738,92R$ 2.191,14até 4x de R$ 547,78 sem jurosou R$ 2.081,58 via Pix20% Desconto -
Drug Transporters-..R$ 2.738,92R$ 2.191,14até 4x de R$ 547,78 sem jurosou R$ 2.081,58 via Pix20% Desconto -
No Deadly Drug-..R$ 182,52R$ 146,02até 2x de R$ 73,01 sem jurosou R$ 138,72 via Pix20% Desconto
Categorias
Pague com
Selos
MYRE EDITORA, COMERCIALIZADORA, IMPORTADORA E DISTRIBUIDORA LTDA - CNPJ: 50.295.718/0001-20 © Todos os direitos reservados. 2026
